Ocellux's first product, E-Carebetics, enables healthcare workers to conduct diabetic retinopathy screenings using a smartphone-attached ophthalmoscope and a mobile app. The scope is able to take clear retinal images on the phone, and the AI app analyzes the images and provides diagnostic data to assist medical workers’ diagnosis. E-Carebetics makes the most widely used device, the smartphone, into a low-cost and portable medical device, enabling rapid screening in and out of the office setting. The AI model has achieved 96% accuracy in detecting the disease and includes an image enhancement feature for less optimal camera. The app also includes an annotation model to mark the location of the disease and provide a detailed report for healthcare workers to make diagnostic decisions. The only step required from the medical worker is to point the camera at the patient's eye and evaluate the AI-generated report.